Our objective was to study the economic impact of the four main endovascular treatment strategies for femoropopliteal arterial disease on payers in the German healthcare system, using up-to-date clinical evidence and current reimbursement amounts.
Our objective was to study the economic impact of the four main endovascular treatment strategies for femoropopliteal arterial disease on payers in the German healthcare system, using up-to-date clinical evidence and current reimbursement amounts.